chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Malaise after 2nd dose; Joint Pain after 2nd dose; Tired after 2nd dose; Nausea; Fever (unmeasured); This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise after 2nd dose), ARTHRALGIA (Joint Pain after 2nd dose), FATIGUE (Tired after 2nd dose), NAUSEA (Nausea) and PYREXIA (Fever (unmeasured)) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced MALAISE (Malaise after 2nd dose), ARTHRALGIA (Joint Pain after 2nd dose), FATIGUE (Tired after 2nd dose) and NAUSEA (Nausea). 13-May-2021, the patient experienced PYREXIA (Fever (unmeasured)). On 14-May-2021, MALAISE (Malaise after 2nd dose), ARTHRALGIA (Joint Pain after 2nd dose), FATIGUE (Tired after 2nd dose), NAUSEA (Nausea) and PYREXIA (Fever (unmeasured)) had resolved.            No Concomitant product use was reported. No treatment information was provided.  The patient after the 2nd dose had fever (unmeasured), nausea, joint pain, tired and malaise for 1.5days.   This case was linked to MOD-2021-395910, MOD-2021-395855 (Patient Link).
Had a headache for about a week after the second dose of the vaccine. It went away for a week or so and then came back worse. Did not respond to Ibuprofen, Alleve, Antihistamines, Flonase, Amoxicillin-Potassium Clavulanate, or Methylprednisolone.
Vaccine of MMR administered right thigh on 12/11/2001. On 12/17/2001 pt developed a fever of 103.6 F and rash on right thigh. Rash was flesh colored and slightly papular with a sand papery texture, diameter of 6 cm.
Patients wife came to pharmacy to let us know the husband had the following symptoms after the first shingrix dose: facial swelling, injection site pain, fever, headache, dizziness, malaise. Of which the facial swelling was most concerning.
going to die from your vaccine; nausea; vomiting; high blood pressure; This is a spontaneous report from contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as a dose number unknown, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient reported that, going to die from your vaccine, nausea, vomiting and high blood pressure. Patient asked, me how long after the vaccine can be nausea, vomiting last. I am already 2 weeks here with nausea, vomiting with the high blood pressure. I am going to die from your vaccine, I am going to die. The patient underwent lab tests and procedures which included blood pressure measurement which was high on an unspecified date. The outcome of the events were unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
severe leg cramps (from hips to toes) x24 hr; chest tightness (feels like wearing a binder); generalized body aches; headache; pins and needles in right foot and arm Tylenol and Motrin  still experiencing chest tightness to date
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Nov2021 as dose 3 (booster), single (Lot number: BBOSSTA) at the age of 59 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Ibuprophen, reaction(s): "Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid.  No follow-up attempts are possible. No further information is expected.
Redness around injection sight (less than a dime),  some swelling and fever in arm around injection
This spontaneous report has been received from a registered nurse concerning an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and pertinent medical history were not reported. On unspecified dates, the patients received improperly stored doses of GARDASIL with a lot # L039066 and expiration date of 19-MAR-2017, (strength, route of administration and dose were not provided). There was no concomitant therapy reported. No adverse event was reported and no product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
This is a spontaneous report from a contactable physician. A 18-year-old female patient received TRUMENBA (Lot# S26985, Exp date 01Jan2019), intramuscular in arm right, on 16Aug2017 at approximately 12:30 PM, at 0.5 ml single, for immunisation and the 2nd dose of MENACTRA (Lot# U5567CA, Exp date 28Jun2018), intramuscular in arm left, on 16Aug2017 at approximately 12:30 PM, at 0.5 ml, for immunisation. The patient's medical history was not reported. Concomitant medications were none. The patient previously took the 1st dose of MENACTRA in Dec2006 for immunisation with no adverse effect.  On 16Aug2017 the patient experienced rash on face, cheeks were red and flushed, headache, fever, chills, body aches, arm sore on the arm that received TRUMENBA. The events were considered medically significant. The arm sore recovered on an unspecified date in Aug2017, all other events recovered on 17Aug2017. The events were considered related to TRUMENBA, and unknown if related to MENACTRA (except for arm sore which was considered as unrelated). Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
I was having a cough, sore throat, headache, shortness of breath, a low-grade fever. I took a home COVID-19 home test and it was positive. I went into a pharmacy and got a test, and it was positive as well. I reached out to my health care provider, and they put me on PAXLOVID and that did help. I was so fatigued and was napping everyday.
Father states that the pt's arm was swollen. On 9/6/01, it was warm and red. Mother took pt to physician who told parents he had an allergic reaction and the physician prescribed Keflex and Cipro. Father states that the child is fine and arm has no swelling and inflammation is gone.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism and Anxiety. Concomitant products included SERTRALINE for Anxiety, LEVOTHYROXINE for Hypothyroidism.    On 18-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details not provided 19 doses of Moderna lot number 009C21A, Expiry Date 10-15-2021 were administered to 19 patients on 10-18-2021. 16 patients received 0.25 ml booster dose and 3 patients received 0.5 ml full dose.    This case was linked to MOD-2021-355973 (Patient Link).
sore arm; tired; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 on an unspecified date (Batch/Lot number was not reported) for COVID-19 immunization. On an unspecified date, the patient experienced: sore arm (non-serious) and tired (non-serious). The clinical course was reported as follows: the patient initially reported adverse events following her daughter's second dose of the Pfizer COVID vaccine. This report was for the reporter (patient herself). The patient stated that neither she or her daughter had any symptoms after the Pfizer COVID vaccine, they just both had a sore arm; and the caller herself was tired but they fared well with the vaccine (as reported).  The patient declined to complete a report on herself and she added that she thought that she was "good", and she expected her side effects that she had, and she was pleased that those were all that she had. The clinical outcome of the events, sore arm and tired, was recovering.  The batch/lot numbers for the vaccine, bnt162b2, were not provided and will be requested during follow up.
Fainting event immediately after administration. Patient recovered in under a minute and did not fall at any point. She was seated the whole time and me and the parents were able to keep her up right. Patient was given water and offerd snacks. She was well within about 10 minutes and was monitroed for for approximately 45 minutes post vaccination. Patient attributed episode to nervousness about getting vaccines.
received first dose approximately 6 weeks ago and then got covid at the end of january. Can she receive the second vaccine?; received first dose approximately 6 weeks ago and then got covid at the end of january. Can she receive the second vaccine?; This is a spontaneous report from a contactable other HCP. A female patient of an unspecified age (reported as 28, units unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via an unspecified route of administration on Jan2021, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  Patient received first dose approximately 6 weeks ago and then got COVID at the end of January 2021. The outcome of the event was unknown.  Information about lot/batch number has been requested.
I was reading an article on my phone and noticed a smear in my bottom of my vision in my left eye. The surrounding words would be fine but the centered word was blurred. After noticing the smear, I went to the Emergency Room / Trauma Center. I was checked in and vitals were taken. My eye was dilated and numbed and checked my retina. As I was there, the problem began to resolve itself and they informed me that I had an Ocular Migraine. They discharged after I said I regained my vision and the blur was gone.
Woke up the next day with a fever and took Advil 600 mg. Slept until 12:20 and when woke up became extremely dizzy and passed out  when walking to use toilet. Took blood pressure at home and it was 90/60
Information has been received from a nurse practitioner concerning a 12 year old female with penicillin allergy and no pertinent medical history who on an unknown date, was vaccinated with the first dose of GARDASIL 0.5 mL, IM. The patient did not experience any difficulties. On 09-SEP-2008, the patient was vaccinated with the second dose of GARDASIL 0.5 mL, IM. There was no concomitant medication. On 10-SEP-2008, the patient experienced over all body rash. The patient's over all body rash persisted. No laboratory tests were performed. The patient was seen in the physician's office (not further specified). The patient sought medical attention by a doctor's office visit. Additional information has been requested.
Some have been sick with them; This case was reported by a pharmacist and described the occurrence of sickness in unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report.   Pharmacist reported that some patients received the dose of Shingrix and got sick. The reporter consented to follow up. This is 1 of the 5 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR257400:same reporter_some patients (sick, 1st dose) US-GLAXOSMITHKLINE-US2020AMR257399:same reporter_individual pt US-GLAXOSMITHKLINE-US2020256890:same reporter_individual pt US-GLAXOSMITHKLINE-US2020256891:same reporter_some patients (late) US-GLAXOSMITHKLINE-US2020AMR257399:
headaches; fevers; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) and PYREXIA (fevers) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches) and PYREXIA (fevers). At the time of the report, HEADACHE (headaches) and PYREXIA (fevers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Vaccination given, possibly 6 minutes post expiration time. This done while pharmacy and vaccines under the supervision
Fever of 101 for 3 days unless I take Tylenol.   Headache, vomiting, nausea, severe fatigue.  On day 3 and still running a fever and have all symptoms.
For the last three days (starting 5/31), I have had enormously swollen feet.  This is very, very unusual for me.  I have only had swollen feet like this after long international flights.    And the level of swelling was not anywhere near as extensive as this. (I have not travelled anywhere since the start of COVID-19.) This "event" started on Monday, 5/31/21. On day 1,  towards the end of the day, I noticed that my left ankle and foot was enormously swollen. There was a clear difference between my left ankle and my right ankle (narrower). And my sandals cut into my foot as they never have. We have a friend who had surgery that removed all her lymph nodes at the top of her leg, so I had seen her lie on her back with her rump against the wall and her feet above her, resting on the wall, to drain out the fluid. So I tried that. I sat against the wall for 1/2 hour to see if the fluids would drain out of my ankles. It helped.  I went to bed thereafter and in the morning both ankles were smaller diameter, with the left ankle still a little larger. On day 2, my left ankle was more of a problem and both ankles were significantly swollen. My left calf was also huge. I sat for most of the evening with my feet elevated and it helped a bit. Today, day 3, I decided to see whether exercise would make a difference. Between meetings (four times today), I walked from the second story of our house to the first floor and back up multiple times (10 times, 5 times, 5 times, 3 times). This did not help. In fact, it is much worse on day 3. At the end of the day today, both ankles were badly swollen, along with both calves. My calves are hard with the impact of the swelling.
Ever since the 3rd day after taking the 2nd shot.  I have had about a degree of fever during the day and night.  Every night since last Tuesday January 27th I have woken up drenched in sweat multiple times a night.  Assuming this is a fever breaking.  I reported this to my doctor today and he advised me to go to this site.  If it continues I will see him next week. I have also had chills and eyes burning during the day ever since the 2nd shot.  The day after the 2nd shot my fever went to 101.5.  But I did not think that irregular since I heard that was a possibility.  The days after though I dont think are a regular vaccine event.
On 6/1/2022, I got my fourth dose of the Pfizer COVID-19 vaccine. On around 6/12/2022, I began to have significant asthma exacerbation, especially when I engaged in any physical activity, such as walking (especially when going uphill). I continued to feel run-down, and I would often have to nap. I saw a doctor in late June 2022, and I was given steroids and antibiotics. I was diagnosed with bronchitis. On 8/19/2022, I had to go back to the doctor, because I had excessive coughing, tightness in the chest, fever, and fatigue. I underwent a chest X-ray and was diagnosed with pneumonia. I was given 20 mg of prednisone, fluticasone, doxycycline monohydrate, albuterol nebulizer, and budesonide. On 8/30/2022, I tested positive for COVID-19. Fortunately, it was a mild case of COVID-19. I had some residual symptoms of pneumonia, which quickly faded. However, I had a fever for the first three or four days I had COVID-19. The fever alternated between 99 and 102 degrees. I had chest tightness in the chest that was not relieved by albuterol. I had a headache that lasted for about five days. I continue to have issues with asthma exacerbation. On 12/12/2022, I had bronchitis. I received a prednisone injection, which helped a great deal. I was also given doxycycline, which also helped. I haven't had bronchitis again since then, but the asthma exacerbation continues. It's now so severe that I can't work out or run. I use albuterol daily. I normally have to have two puffs in the morning, and I frequently have four puffs during the day. Since about June 2023, I've had use an albuterol nebulizer in the morning and before I go to bed. I also have to do cycles of budesonide.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 74-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. The patient was prescribed zoster vaccine live (ZOSTAVAX) by a healthcare provider for long-term prevention of shingles and zoster-related conditions. On or around 15-SEP-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) by a pharmacist at a pharmacy (lot#, expiration date, dose and route of administration were not specified). On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
"Wednesday January 20th I received my second COVID vaccine, returning to work the next day. I felt some fatigue and chills through Friday, but woke up Saturday the 23rd feeling normal, except for a rash developing on my neck and the left side of my head. By Sunday, it spread, so I made a virtual appointment. Yesterday, it got worse, so I made an appointment with my primary care and saw him in the afternoon. Apparently, I was his second patient yesterday with the same diagnosis: shingles trigglered by the COVID - 19 vaccine."
got the shot years ago then got shingles/Suspected vaccination failure; got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's sibling. The patient got the shot just a few years prior to the reporting and when she move back, she got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting
Before the shot the patient was very nervous.  5 Minutes later she lost consciousness in her chair but quickly recovered, with dizziness, tunnel vision, sweating, shivering, nausea, weakness. She got better with resting her head down by her knees, had some water, then stood up to go to the bathroom due to nausea, but didn't make it and vomited 2 times. After resting on the floor with pharmacist supervision for about 20  minutes she began to feel better. I called her boyfriend who came to pick her up. She did not want the ambulance.
Breakthrough case admission after 3 vaccines ; mOderna 3/9/21 lot# 030A21A;  Moderna 4/6/21 lot# 017B21A;  Moderna 11/13/21 lot# 033F21A
Uncontrolled shaking Severe Chills and fever. Could not stop shaking at all. I was in the military for 20yrs and never had a problem.
caller have a heart disease; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "caller have a heart disease".  Additional Information: Reporter calling in about the vaccines that were offered one from Pfizer, Moderna and there's another one.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Arm pain, fever, erythema of (R) arm 5cm x 3cm very tender to palpation, tx with prednisone & AUGEMTIN.
fever 106.2 ax, chills, unconsolable crying; observed @ ER for 1 hrs;